AI-generated summary
The authors report a small randomized, double-blind, placebo-controlled pilot trial of skin adhesive low-level light therapy in women with dysmenorrhoea. Twenty-one women received active treatment and ten received placebo, with pain measured by visual analog scale over six months. The authors report an 83 % pain reduction rate in the active group and a statistically significant difference from placebo, and they suggest the approach might be effective.
- Participants
- 31
- Who or what was studied
- Women with dysmenorrhoea (31 women: 21 active LLLT, 10 placebo)
- Limits stated in the abstract
- The abstract describes a small pilot trial with an uneven group split and does not state the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Placebo-controlled, Visual analogue scale, Statistical significance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.